X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (59) 59
index medicus (50) 50
female (47) 47
male (46) 46
middle aged (43) 43
aged (31) 31
diabetes (30) 30
adult (28) 28
endocrinology & metabolism (26) 26
type 2 diabetes (24) 24
diabetes mellitus, type 2 - drug therapy (22) 22
diabetes mellitus (18) 18
double-blind method (16) 16
cardiovascular disease (15) 15
hypoglycemic agents - therapeutic use (15) 15
risk factors (15) 15
medicine, general & internal (14) 14
diabetes mellitus, type 2 - blood (13) 13
diabetes mellitus, type 2 - complications (13) 13
risk (13) 13
treatment outcome (13) 13
cardiovascular diseases (11) 11
research (11) 11
body mass index (10) 10
care and treatment (10) 10
genetics & heredity (10) 10
glucose (10) 10
medical and health sciences (10) 10
medicin och hälsovetenskap (10) 10
metformin (10) 10
abridged index medicus (9) 9
analysis (9) 9
clinical trials (9) 9
diabetes mellitus, type 2 - genetics (9) 9
disease (9) 9
follow-up studies (9) 9
genetic aspects (9) 9
cardiovascular diseases - prevention & control (8) 8
dosage and administration (8) 8
drug therapy (8) 8
incidence (8) 8
insulin (8) 8
internal medicine (8) 8
latvia - epidemiology (8) 8
myocardial infarction (8) 8
polymorphism, single nucleotide (8) 8
adolescent (7) 7
drug therapy, combination (7) 7
genotype (7) 7
glycated hemoglobin a - metabolism (7) 7
hypoglycemic agents (7) 7
hypoglycemic agents - administration & dosage (7) 7
medicine (7) 7
polymorphism (7) 7
polymorphism, single nucleotide - genetics (7) 7
prevention (7) 7
aged, 80 and over (6) 6
biochemistry & molecular biology (6) 6
blood glucose - drug effects (6) 6
cerebral infarction (6) 6
cholesterol (6) 6
follow-up (6) 6
health risk assessment (6) 6
heart diseases (6) 6
hypoglycemic agents - adverse effects (6) 6
latvia (6) 6
management (6) 6
mellitus (6) 6
metabolism (6) 6
patient outcomes (6) 6
peripheral vascular disease (6) 6
population (6) 6
prevalence (6) 6
stroke (6) 6
therapy (6) 6
thiazolidinediones - therapeutic use (6) 6
young adult (6) 6
alleles (5) 5
blood glucose - metabolism (5) 5
blood pressure (5) 5
cardiovascular-disease (5) 5
case-control studies (5) 5
dextrose (5) 5
diabetes therapy (5) 5
diagnosis (5) 5
diet (5) 5
endocrine system diseases (5) 5
enzymes (5) 5
expression (5) 5
genetics (5) 5
genome-wide association (5) 5
heart attacks (5) 5
hemoglobin (5) 5
hyperglycemia (5) 5
insulin glargine (5) 5
life sciences (5) 5
metformin - therapeutic use (5) 5
mortality (5) 5
nutritional and metabolic diseases (5) 5
obesity (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE MEDICINE, ISSN 1078-8956, 06/2012, Volume 18, Issue 6, pp. 926 - 926
This study establishes a mechanism for metabolic hyperalgesia based on the glycolytic metabolite methylglyoxal. We found that concentrations of plasma... 
MEDICINE, RESEARCH & EXPERIMENTAL | ACTIVATION | FOREBRAIN | SENSITIVE METHOD | RAT | ROOT GANGLION NEURONS | BIOCHEMISTRY & MOLECULAR BIOLOGY | BLOOD-FLOW | CELL BIOLOGY | PERIPHERAL NEUROPATHY | RESISTANT SODIUM-CHANNELS | EXPRESSION | GLYOXALASE-I
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2017, Volume 377, Issue 13, pp. 1228 - 1239
This trial, which compared once-weekly exenatide plus usual care with usual care alone in patients with type 2 diabetes with or without previous cardiovascular... 
MEDICINE, GENERAL & INTERNAL | RISK | EVENT LOWERING EXSCEL | GLUCOSE CONTROL | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Male | Exenatide | Peptides - administration & dosage | Incidence | Cardiovascular Diseases - complications | Hypoglycemic Agents - administration & dosage | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Venoms - administration & dosage | Female | Diabetes Mellitus, Type 2 - complications | Double-Blind Method | Drug Administration Schedule | Venoms - adverse effects | Kaplan-Meier Estimate | Diabetes Mellitus, Type 2 - blood | Least-Squares Analysis | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Peptides - adverse effects | Type 2 diabetes | Usage | Patient outcomes | Outcome and process assessment (Health Care) | Reports | Dosage and administration | Drug therapy | Observations | Myocardial infarction | Cerebral infarction | Diabetes mellitus | Pancreatitis | Amylin | Cardiovascular disease | Patients | Thyroid carcinoma | Studies | Side effects | Pancreatic carcinoma | Pancreatic cancer | Diabetes | Health risk assessment | Heart diseases | Endocrinology | Pharmaceuticals | Clinical Medicine | Medical and Health Sciences | Klinisk medicin | Medicin och hälsovetenskap
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2015, Volume 373, Issue 3, pp. 232 - 242
Journal Article
by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article